Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other financing activities (2016 - 2025)

Amphastar Pharmaceuticals has reported Other financing activities over the past 9 years, most recently at $8000.0 for Q4 2025.

  • For Q4 2025, Other financing activities rose 136.36% year-over-year to $8000.0; the TTM value through Dec 2025 reached $687000.0, down 15.81%, while the annual FY2025 figure was $687000.0, 15.81% down from the prior year.
  • Other financing activities for Q4 2025 was $8000.0 at Amphastar Pharmaceuticals, up from $4000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $10.4 million in Q3 2023 and troughed at -$22000.0 in Q4 2024.
  • A 5-year average of $876466.7 and a median of $252000.0 in 2024 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: crashed 104.49% in 2024 and later soared 25400.0% in 2025.
  • Year by year, Other financing activities stood at $308000.0 in 2021, then crashed by 99.03% to $3000.0 in 2022, then surged by 16233.33% to $490000.0 in 2023, then crashed by 104.49% to -$22000.0 in 2024, then surged by 136.36% to $8000.0 in 2025.
  • Business Quant data shows Other financing activities for AMPH at $8000.0 in Q4 2025, $4000.0 in Q3 2025, and $253000.0 in Q2 2025.